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Biologically functional β-cells proliferate at an extremely low rate with limited turnover 
capacity. This cellular property hinders cell-based therapy for clinical applications.  Many 
attempts have been made to develop techniques that allow large quantities of production of 
clinically relevant islet β-cells in vitro. A line of studies demonstrates that functional β-cells can 
proliferate under certain circumstances, providing hope for generating and expanding these cells 
in vitro and transplanting them into the recipient. In this study, we showed that a membrane 
substrate offers a better niche for beta cell proliferation and insulin secretion. Mouse beta cells 
were grown on  a tissue culture plate (TCP) as a control as well as on polyethylene terephthalate 
(PET) membrane, and  cell numbers were counted four times at  48 hours intervals. The cell 
doubling time was shortened from 64.7±0.4 h for beta cells grown on TCP, to 38.6±0.5 h (p-
value 0.03) for those grown on PET membrane substrate with a pore size of 1µm. In addition, 
there was an increase of approximately ten to thirteen fold in insulin gene expression in cells 
cultured on PET compared to that on TCP (p-value 0.02). Furthermore, to investigate the 
mechanism of the enhanced proliferation and insulin production using membrane substrate, the 
expression profile of eighty-four genes that are involved in the apoptotic pathway were measured 
by quantitative real time polymerase chain reaction (qRT-PCR). Enhancements in Akt and Bcl2 
gene expression were detected. These findings demonstrate that a membrane substrate can offer 
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1.0 REVIEW OF LITERATURE 
1.1 OVERVIEW: 
Pancreatic β-cells are considered one of the most important cells in the islets of Langerhans 
in the endocrine tissue of the pancreas. These cells are responsible for insulin production in 
response to blood glucose levels. Diabetes mellitus is a result of either insulin deficiency, or 
sugar unregulated insulin secretion (Klöppel, Löhr, Habich, Oberholzer, & Heitz, 1985). Type I 
and II diabetes are two common types of the disease. Type I diabetes (T1D) results from the 
autoimmune destruction of β-cells, making the body incapable of maintaining normal glycemia 
in these patients. In Type II diabetes (T2D), either the body does not produce enough insulin due 
to a decrease in functional β-cell mass, or the insulin secretion does not respond to elevated 
glucose levels in the blood. Diabetes induces other diseases, including heart disease and stroke, 
high blood pressure, kidney disease, and blindness. The CDC estimated that 25.8 million people 
of the U.S. population had this disease in 2011(Centers for Disease Control and Prevention, 
2011). The World Health Organization (WHO) suggested that the global number of diabetic 
patients would reach 300 million as well as become the 7th leading cause of death by the year 
2030 (Alwan, 2011). Current treatment for T1D includes insulin supplementation by either tablet 
or injection (Daneman, 2006), or organ transplantation, which has its own complications 
including the unavailability of donors and histocompatibility matching issues (Shapiro et al., 
2000). Medical treatment for T2D is fairly limited. Driven by the urgent need to treat patients 
suffering from diabetes, intensive research efforts have been made to create biologically 
functional islet tissues that can be used to replace diseased islets and regenerate a healthy tissue 




One of the main challenges that remains in adult pancreatic β-cell therapy is the extremely 
low proliferation rate which is approximately 0.3% a day in aged adult mice and the minimum 
replication rate in adult humans (Ribaux et al., 2007). Fortunately, it is now well known that β-
cell mass expansion can occur in early postnatal life, pregnancy, and animal models which have 
been genetically modulated (Buteau et al., 2004; Nir, Melton, & Dor, 2007; Rieck & Kaestner, 
2010). For this reason, it is important to fully understand the molecular mechanisms that 
facilitate enhanced pancreatic β-cell proliferation so that cells can be cultured in an environment 
suitable for in vitro production. β-cell proliferation inducers can be classified into extrinsic and 
intrinsic categories. Extrinsic mitogens include: glucose, amino acids, insulin and insulin like 
growth factors (IGFs), prolactin (PRL), placental lactogen (PL), glucagon-like peptide-1 (GLP-
1), growth hormone (GH), Hepatocyte growth factor (HGF), epidermal growth factors (EGF), 
Transforming growth factor (TGF), and extracellular matrix (ECM) (Gasparo, Milner, Norris, & 
Milner, 1978; Garofalo et al., 2003; SJÖHOLM, 1996). On the other hand, the most prominent 
intrinsic factors are: cyclins, cyclin dependent kinases (CDKs), and cyclin dependent kinase 
inhibitors (CKIs) (Heit, Karnik, & Kim, 2006). This review focuses on the most important 
extrinsic mitogens and associated signaling pathways that are involved in the process of β-cell 
proliferation. The review also introduces advanced approaches and applications in the field of 
islet β-cell expansion and biological functionalization. 
 
1.2 NATIVE β-CELLS AND THEIR SRROUNDINGS   
Understanding the physiological nature of the native β-cell is a prerequisite for establishing 
niches required for supporting islet β-cells. Islets of Langerhans are comprised of five types of 
cells: α, β, δ, ε, and PP-cells. These cells work as a microorgan to maintain glucose homeostasis. 
The β-cell is the most abundant and important cell in the islets, which sense the circulating 
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glucose level in the blood and respond to glucose levels by secreting insulin accordingly 
(Eberhard & Lammert, 2009). β-cells receive their regulation from a pancreatic and non-
pancreatic environment promoting their function and proliferation (Eberhard & Lammert, 2009). 
First, a dense vascular network exists within the islets and facilitates efficient oxygen and insulin 
transfer. β-cells interact with the endothelial cells of the capillary network through the vascular 
basement membrane (BM). β-cells secret vascular endothelial growth factor (VEGF) to promote 
vascular development, whereas the endothelial cells produce a basement membrane rich with 
laminin to support the insulin gene expression and secretion from β-cells and promot β-cell 
proliferation (Nobukini & Thomas, 2004). Second, cell to cell contacts between β-cells, through 
several transmembrane receptors, have a great impact on optimizing the insulin gene expression, 
and glucose stimulated insulin secretion (GSIS) (Wojtusciszyn, Armanet, Morel, Berney, & 
Bosco, 2008). Third, β-cells interact with α-cells in reciprocal secretory fashion to maintain 
glucose homeostasis (Unger & Orci, 2010). Fourth, islets are rich with neurons from the 
sympathetic and parasympathetic nervous systems.   Interaction between β-cells and 
parasympathetic neurons activate specific receptors to induce GSIS, whereas sympathetic 
neurons inhibit insulin secretion as a part of the physiological glucose homeostasis (Ahrén, 
2000).  
In addition, β-cells interact with non-pancreatic tissues such as: liver, bone, fat and gut, and 
endocrine cells of the intestine (Eberhard & Lammert, 2009). These cells secrete integrins which 
bind to a G-coupled receptor on the β-cell surface to stimulate insulin secretion and β-cell 
proliferation (Drucker, 2007). In the process of islet isolation all of the vascular and nerve 
connections are destroyed by the enzymatic digestion of the pancreas and islet purification 
through density centrifugation, which could be the major cause of malfunction of the β-cell and 
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its survival after isolation procedures (Merani & Shapiro, 2006; Wang, Paraskevas, & 
Rosenberg, 1999). Motivated by the need to create an optimal niche for β-cell transplantation, 
researchers are exploring the most effective biological materials and accessories for creating a 
niche that can last long enough after transplantation and would be beneficial for cells to re-
communicate with their surroundings. In addition, knowing the signaling pathways and 
molecular mechanisms would enable manipulating cell proliferation as well as optimizing insulin 
secretory function. This section is thus discussed in detail in the following section.  
 
1.3 EXTRINSIC MITOGENS  
1.3.1 Glucose 
Glucose is a well-known physiological regulator. It is one of the important regulators of β-
cell proliferation, since the primary function of β-cells is to lower blood glucose levels by insulin 
secretion. Evidence indicating the role of glucose in β-cell proliferation have been reported in 
several studies both in in vitro and in vivo. Glucose has been shown to be an important 
requirement for cell growth in fetal and neonatal β-cell (Swenne, 1982), insulinoma cell lines 
(Gahr et al., 2002), primary islets (Hoorens, Van, Klöppel, & Pipeleers, 1996), as well as human 
β-cells (Tyrberg, Eizirik, Hellerström, Pipeleers, & Andersson, 1996).  In vivo glucose infusion 
in diabetic mice and rats ultimately resulted in increasing β-cell mass (Alonso et al., 2007; C. 
Bernard, Ktorza, Saulnier, & Berthault, 1999; Paris, Bernard-Kargar, Berthault, Bouwens, & 
Ktorza, 2003).  
The signaling pathways which correlate glucose levels with β-cell quantity, proliferation, and 
apoptosis have not yet been entirely developed.  Several pathways thought to be involved are: (1) 
insulin autocrine effect, (2) calcium signaling, and (3) the TSC2/mTOR inhibitory signaling 
pathway (Chang-Chen, Mullur, & Bernal-Mizrachi, 2008). In vitro studies demonstrated that 
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glucose induces intracellular signaling molecules such as phosphatidylinositol 3'-kinase (PI3K), 
protein kinase B (PKB), glycogen synthase kinase-3 (GSK-3), extracellular signal-regulated 
kinase (ERK)1/2, and mammalian target of rapamycin (mTOR), as well as insulin receptor 
substrate 2 (IRS2) (Ohsugi et al., 2004; Vaulont, Vasseur-Cognet, & Kahn, 2000). Activation of 
insulin receptor leads to the activation of the Akt signaling pathway which is considered to be 
one of the main pathways of β-cell proliferation (Bernal-Mizrachi, Wen, Stahlhut, Welling, & 
Permutt, 2001; Tuttle et al., 2001). Moreover, this activation is down regulated by mTOR 
signaling triggered by an increase in ATP production and leads to the subsequent inactivation of 
AMP kinase (AMPK) (Nobukini & Thomas, 2004). Finally, the calcium signaling pathway also 
has a significant influence on phosphates level. An investigation of the importance of this 
pathway has been conducted by deleting the calcineurin regulatory subunit, calcineurin b1 
(Cnb1). This study showed reduced β-cell proliferation and the development of age related 
diabetes. The correction for this defect was made by expressing the active nuclear factor of 
activated T cell cytoplasmic 1 (NFATc1), which is a downstream transcription factor in this 
pathway (Heit et al., 2006). Activation of transcription factors cAMP response element-binding 
protein (CREB) and serum response factor (SRF) improved β-cell growth rate through the 
glucose/ calcium pathway (Bernal-Mizrachi, Wice, Inoue, & Permutt, 2000; Jhala et al., 2003).   
Although the moderate glucose elevation causes an increase in β-cell growth and survival, 
prolonged exposure to high concentrations of glucose is the main cause of β-cell deterioration 
and apoptosis. This condition, called glucotoxicity, is caused by several mechanisms that are not 
fully understood (V. Poitout, Olson, & Robertson, 1996; V. Poitout & Robertson, 2002).  A line 
of studies found a number of transcriptional regulators that are sensitive to the level and duration 
of glucose and insulin gene expression such as MafA, NFAT (M. C. Lawrence, Bhatt, Watterson, 
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& Easom, 2001; M. C. Lawrence, Bhatt, & Easom, 2002), somatostatin transcription factor-1 
(STF-1), pancreatic and duodenal homeobox 1 (Pdx-1), and the insulin control element (ICE) 
(Sharma, Olson, Robertson, & Stein, 1995).  It was shown that these proteins are expressed in 
the presence of 0.8 mM glucose as well as a prolonged exposure to a high level of 11.1 mM 
glucose (V. Poitout et al., 1996). In addition, MafA protein level is able to restore insulin 
expression in β-cell lines along with the present of prolonged high glucose levels (Harmon, 
Stein, & Robertson, 2005). High glucose concentrations have also been shown to inactivate AMP 
protein kinase (AMPK) in β-cells and result in impaired glucose-stimulated insulin secretion 
(GSIS) due to lipid accumulation which leads to the deterioration of β-cell function (Da et al., 
2003; Nyblom, Sargsyan, & Bergsten, 2008; R. H. Unger, Zhou, & Orci, 1999).  
Another set of studies revealed that glucose toxicity may lead to oxidative stress in organelles 
such as in the endoplasmic reticulum and mitochondria (Fridlyand & Philipson, 2004; Nyblom, 
Thorn, Ahmed, & Bergsten, 2006). Increase in oxidative stress causes a reduction in binding of 
Pdx1 and MafA to the insulin gene in the pancreas which, in turn, results in defective insulin 
gene expression and hormone secretion (Harmon et al., 2005; Robertson & Harmon, 2006). It is 
clear that reactive oxygen species (ROS) activate stress-induced pathways, including nuclear 
factor kB (NF-kB), c-Jun N terminal kinase (JNK), and hexoanimase pathways (Kaneto et al., 
2002; Kawasaki, Abiru, & Eguchi, 2004). The subsequent JNK signaling event leads to the 
inactivation of IRS-1 by its phosphorylation on Ser307 (Aguirre, Uchida, Yenush, Davis, & 
White, 2000).  A recent study suggested that hypoxia is another cause for the malfunction of β-
cells.  Expression of transcription factor hypoxia-inducible factor (HIF) plays an adverse role in 
β-cell function (Gunton et al., 2005). Under exposure to a high glucose level, an alteration in the 
profile of β-cell gene expression occurs, including a switch from aerobic to anaerobic glycolysis 
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that leads to impaired GSIS and glucose intolerance. This was investigated through the deletion 
of the regulatory protein von Hippel-Lindau (VHL) protein for controlling the degradation of 
HIF which reduces the cellular oxygenation level and causes hypoxia. VHL/HIF oxygen-sensing 
mechanisms play a critical role in glucose homeostasis through decreasing islet oxygenation 
level and negatively impacting β-cell function (J. Cantley et al., 2009; Puri, Cano, & Hebrok, 
2009).  
Furthermore, chronic hyperglycemia leads to excessive accumulation of Ca+2 in the cytosol 
which is a proapoptotic signal that induces β-cell dysfunction and destruction (Grill, 2001). 
Other potent apoptosis pathways were shown to be related to interleukin-1 β which inhibits β-
cell function and promotes Fas-triggered apoptosis in part by activating the transcription factor 
NF-kB during the autoimmune process of T1D pathogenesis (Maedler et al., 2002). However, 
knowledge of the signaling pathway involved in chronic hyperglycemia remains elusive. In 
particularly, the targets and the downstream effects of glucotoxicity have not yet been 
completely elucidated.   
 
1.3.2 Growth factors and signaling pathways 
Insulin growth factor (IGF)  
Expressions of insulin growth factor I (IGF-I) and II (IGF-II) and their receptor (IGFR) were 
found in different stages of pancreatic development.  In fact, their expressions act as signal for 
stimulating β-cell proliferation (R. N. Kulkarni, 2005). IGF-I and IGF-II are able to enhance β-
cell proliferation in rat islets and insulinoma cell lines in vitro (Hogg, Han, Clemmons, & Hill, 
1993). Interestingly, the over-expression of IGF-I results in enhanced proliferation of β-cells in 
transgenic mice but not the size of islets, whereas the over-expression of IGF-II leads to 
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abnormal islet morphology with an enlarged irregular shape (George et al., 2002; Petrik et al., 
1999).        
Studies also demonstrated that insulin receptor (IR) is a stimulator for β-cell proliferation (R. 
N. Kulkarni et al., 1999), where the Akt and MAPK signaling pathways are involved (Saltiel & 
Kahn, 2001). Reduction in the IR by up to 80% in MIN6 cells lead to the reduction of growth 
rate, suggesting that insulin plays a crucial role as a growth factor for this insulinoma cell line 
(M. Ohsugi et al., 2005). In addition, the effect of IR substrate 1 and 2 (IRS1 & 2) have also been 
explored as they are modulators in the insulin/IGF signaling cascade. A heterozygous mutation 
in IRS1/IR in mice showed a 400-fold increase in circulating insulin in parallel to severe insulin 
resistance with striking hyperplasia in the β-cell mass by 40-50-fold (Bruning et al., 1997). In 
contrast, animal models deficient in IRS-2 showed abnormalities such as low proliferation, low 
Pdx-1 expression, small islet size, and an increase in apoptosis (Withers et al., 1998). Moreover, 
IRS-2 over-expression is associated with glucose stimulation in insulinoma cells. It exhibits a 
synergistic increment in β-cell proliferation in glucose/IGF-1induced manner in vitro (Lingohr et 
al., 2002). Another study reported that IRS-2 controls other growth promoting mutagens such as 
exendin-4, which protects β-cells from human islet amyloid polypeptide-induced cell damage 
(Fan, et al., 2010; Park et al., 2006). All of these studies suggested that the downstream signaling 
of insulin and IGF receptors are essential for maintaining β-cell mass and proliferation.  
 
Akt/PKB signaling pathway 
Akt is also known as protein kinase B (PKB), and is proposed to be a crucial modulator of 
IRS-2-mediated signals in β-cells. Deficiency in AKT2 has shown a negative impact on β-cell 
proliferation, which provides an evidence of its importance in the signaling cascade (Garofalo et 
al., 2003). On the contrary, AKT2 over expression induced β-cell proliferation via enhancing 
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resistance to apoptosis and improving insulin secretion (Bernal-Mizrachi et al., 2001) , (Tuttle et 
al., 2001). Some downstream targets such as forkhead transcription factor 1 (FOXO1), Glycogen 
synthase kinase 3 beta (GSK3β), and the mammalian target of rapamycin (mTOR) are down-
regulated by the Akt signaling pathway and Akt functions have been described elsewhere (Kaiser 
et al., 2013; Nakae et al., 2002; Tanabe et al., 2008).  
 Pdx-1, also known as insulin promoter factor 1 (IPF1) has been investigated as an ultimate 
transcription factor of Akt signaling, its phosphorylation and nuclear inclusion plays an 
important role in β-cells proliferation and function (McKinnon & Docherty, 2001). However, it 
is still unknown how Pdx-1 regulates β-cell proliferation.  In addition, Pdx-1 can restore β-cell 
function in IRS2 knockout mice, suggesting that the dysregulation of Pdx-1 by IRS2 is directly 
related to the development of T2D (Kushner et al., 2002). 
There are multiple evidences for the inverse correlation between the 
forkhead transcription factor 1 FOXO1and the Pdx-1expression. A group of studies showed 
several mechanisms in which FOXO1 can antagonize Pdx-1. FOXO1 suppression can be done 
through the competition binding of forkhead box protein A2 (FoxA2) protein to Pdx-1 promoter 
region and restoring Pdx-1expression level (Kitamura et al., 2002). This was further affirmed by 
the expression of Pdx-1 in β-cells which contain cytoplasmic FOXO1 but not nuclear FOXO1 
(Kitamura et al., 2002). A recent study also confirmed that FOXO1 inhibits β-cell neogenesis but 
it is required for the maintenance of insulin secretion under metabolic stress (Kobayashi et al., 
2012). In addition, FOXO1 can lead to a nuclear exclusion of Pdx-1in oxidatively stressed β-cell 
as a suppression mechanism (Kawamori et al., 2006). However, it is unclear the type of molecules 
that are stimulated by Pdx-1 as well as the correlation of the mechanism of these molecules with 
Pdx-1 to induce β-cell proliferation.                
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Prolactin, placental lactogen, and HGF   
  Several other growth factors, such as prolactin (PRL) and placental lactogen (PL), can also 
enhance β-cell proliferation rate both in vitro and in vivo. Prolactin as well as PL are highly 
expressed during pregnancy and have beenshown to be involved in increasing β-cells mass 
(Vasavada et al., 2000). In rodent studies, injection of PRL or PL leads to higher beta cell growth 
(Parsons et al., 1992). Moreover, transgenic mice over- expressing PL demonstrated a higher 
growth rate associated with hyperinsulinemia (Parsons et al., 1992). On the contrary, mice 
lacking PRL receptors reduced β-cell mass (Freemark et al., 2002). PRL and PL both bind to the 
PRL receptor. The PRL receptor belongs to the cytokine receptor family in the JAK/STAT 
signaling pathway (Nielsen, 2001). Thus, these two growth factors trigger β-cell proliferation 
through signaling pathway JAK2/STA5 as illustrated in Table 1.   
Hepatocyte growth factor (HGF) is a mesenchyme-derived growth factor involved in 
proliferation, migration, and differentiation of several types of tissues (Matsumoto & Nakamura, 
1996). Deletion of HGF demonstrated glucose intolerance and impaired glucose stimulated 
insulin secretion (GSIS). A protective effect against apoptosis and increase of proliferation was 
exhibited in induced dysfunction mice injected with the exogenous HGF gene (Dai et al., 2003). 
Thus, HGF seems to be an attractive potential target for therapy. HGF binds to c-met receptor 
and activates MAPK and PI3K/Akt pathways which are responsible for β-cell proliferation 
(García-Ocaña et al., 2001). It seems like a mechanism of action regarding the involvement of 
the signal pathway is complicated and unpredictable. For instance, insulinoma cells (INS-1) 
treated with HGF exhibit an increase in Protein kinase C expression, advocating the presence of 




Transforming growth factor-beta (TGF-β)  
Transforming growth factor (TGF) has two classes of polypeptide growth factors, TGF-α and 
TGF-β. TGF-β is an important regulator in pancreas development and function. They have been 
implicated in the pathogenesis of cancer, autoimmune disease, and diabetes. Several studies have 
reported that impaired TGF level can lead to the onset of both type1 and type 2 diabetes ( Rane, 
Lee, & Lin, 2006). Impaired TGF-β is related to the progression of T1D in non-obese diabetic 
(NOD) mice. The cause of diabetes in these mice was autoimmune destruction of islets resulting 
insulin deficiency (Anderson & Bluestone, 2005). An adenoviral expression vector encoding 
TGF was transfected to the NOD mouse islet cells. The experimental result suggested a 
protection to the NOD mouse islet cells from apoptosis and immune distraction and delay in 
diabetes occurrence for 22 days compared to only 7 days in the vector transfected control 
(Suarez-Pinzon, et al., 2002). Microarray on isolated intact human islets incubated in low and/or 
high glucose, revealed a highly regulated TGF signaling in the human islets. This suggests that 
TGF is involved in glucose metabolism and β-cell function as well (Drucker, 2006; Shalev et al., 
2002).   
  
 




MAPK Akt Ca+2 
signaling 
Jak/Stat Smda β- catenin 
Glucose √  √    
Insulin/IGF-1  √ √    
PRL/PL    √   
HGF √ √ √    
TGF     √  
GLP-1/GIP √ √ √   √ 
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1.3.3 Incretins  
Incretins are a group of hormones that lead to an increase in the amount of insulin released from 
the β-cells. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide 
(GIP) are the two types of incretin hormones that have been well investigated. They are secreted 
from the intestine upon glucose ingestion to stimulate insulin secretion. These two hormones 
have been shown to be involved in increasing β-cell proliferation and decreasing cell apoptosis 
(Drucker, 2006). GLP-1 infusion into glucose-intolerance rats caused an increase in β-cell mass. 
Likewise, an increase in β-cell size and neogenesis was observed in mice treated with GLP-1. 
Moreover, GLP-1 has an anti-apoptotic effect in freshly isolated human islets (Farilla et al., 
2003). Buteau et al. found that GLP-1 enhances the binding of NFκB transcription factor to two 
anti-apoptotic genes: protein-2 and Bcl-2, resulting in augmentation of the expression of the anti-
apoptotic proteins (J. Buteau et al., 2004). Therefore, GLP-1 has been approved by the FDA for 
use in T2D treatment (Issa & Azar, 2012). GIP has also shown to be a synergistical mitogen 
inducer with glucose and a pleiotropic growth factor for insulin production on INS-1 β-cells 
(Trümper et al., 2001). Indeed, GIP is strictly glucose dependent and it does not show any effect 
during a low blood glucose level. Thus, GIP seems to act as a blood glucose stabilizer with 
inverse glucose-dependent effect on pancreatic insulin (Christensen et al., 2011). In addition, the 
binding of GIP-1 to its G-protein coupled receptor (GLP1R) activates downstream targets 
including cAMP and PKA, intracellular calcium, and Pdx-1. In fact, many GLP1R consequence 
events seem to be related to Pdx-1 expression (Holz et al., 1999; Wang & Rosenberg, 1999; 
Tsuboi et al., 2003). Mouse islet β-cell MIN6 treated with GLP1R can activate the PI3K/Akt 
signaling pathway and trigger a significant increase in IRS2 (Li et al., 2005). On the contrary, 
inhibition of both c-SRC and EGFR suppresses GLP1R-mediated PI3K pathway in INS-1 cells 
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(Buteau, Foisy, Joly, & Prentki, 2003). Recently, GLP-1 was found to be able to induce β-cell 
proliferation by increasing the β-catenin nuclear content and increasing cyclic D1 expression 
(Shao et al., 2013). 
 
1.3.4 Extracellular matrix  
 The extracellular matrix (ECM) is part of the tissue composed of multiple proteins and 
polysaccharides, and provides structural support to the cells and instructional guidance as well. 
Adult human islets are surrounded by an incomplete capsule constituted from a single layer of 
fibroblasts and collagen fibers. Additional matrix protein is attached to this capsule and known 
as periinsular basement membrane (BM).  Mechanical and chemical signaling interactions 
between cells and ECM are known to regulate several physiological aspects including: survival 
(Nagata et al., 2002), proliferation (Beattie et al., 1996), and insulin secretion in islets (Kaido et 
al., 2006). In living tissue, cells synthesize ECM components and deposit them to form a niche. 
A niche not only affects the tissue composition and mechanical properties, but also determines 
cellular fate. As aforementioned, islet β-cells can rarely proliferate in vitro, thus, many attempts 
have been made to assess niches required for β-cell expansion. In a recent study, human islet 
cells were cultured in two ECM environments: rat ECM (804G) and bovine corneal endothelial 
ECM (BCEC) in the presence of GLP-1 analogue. It was observed that there is approximately 
0.082±0.034% proliferation of islet β-cells in a treated/BCEC culture condition. These results 
indicate that adult human β-cell proliferation can occur in vitro but remains an extremely rare 
event within an environment of certain ECM and signaling molecules (Rutti et al., 2012). In 
another study, fully differentiated human adult insulin-producing β-cells were unable to 
proliferate in vitro regardless of whether or not the presence of human growth hormone (hGH) 
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and the GLP-1 analogue liraglutide. However, hGH and GLP-1 enhaced rat β-cell proliferation 
(Parnaud et al., 2009).  
Since an interaction of ECM with integrins triggers an intracellular signaling cascade and 
modulates the level of gene expressions that control cell behavior (Juliano & Haskill, 1993), the 
effect of integrin on β-cell proliferation has also been explored. Studies suggest that adult human 
islets are expressing special types of integrins including α3, α5, αv, α6, β1, β3 and β5 (R. N. 
Wang & Rosenberg, 1999). Laminin-5 interacting with α6β1 integrin allows rat β-cell 
proliferation (Bosco, Meda, Halban, & Rouiller, 2000). Among ligands for the α3β1 integrin, 
including fibronectin, laminin, collagen I, and collagen IV, only collagen I and IV promote rat 
INS-1 cell viability and proliferation (Krishnamurthy et al.,2008). Collagen type I, IV, and 
laminin can increase survival rate of islets after isolation procedures (Pinkse et al., 2006). 
Nikolova and his co-workers identified laminins working as endothelial signals for promoting 
insulin secretion of β-cells, where this improvement relys on the interaction between β1 integrin 
and the laminins (Nikolova et al., 2006). 
 
1.4 TISSUE ENGENERING APPROACHES 
As mentioned previously, there is considerable interest in understanding the most important 
regulators and the mechanisms that can stimulate pancreatic islet growth in vitro. Tissue 
engineering approaches have been explored by culturing cells with highly porous scaffold 
biomaterials to generate a three dimensional (3D) environment for improving islet growth and 
survival, as well as normal insulin secretion. A line of studies demonstrated that polyethylene 
glycol (PEG) hydrogel scaffold can mimic cell-cell communication microenvironment required 
for insulin-secreting β-cells (Lin & Anseth, 2011; Weber, 2008; Weber, 2007). Bernard and his 
co-workers developed a PEG hydrogel-based microwell cell culture system using 
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photolithography technique (Bernard, Lin, & Anseth, 2012). Mouse β-cells formed aggregates in 
PEG hydrogels and demonstrated more than 90% cellular viability in a week long culture. 
Furthermore, aggregated cells showed considerable increase in insulin secretion compared with 
single cell culture conditions (Bernard et al., 2012). This study indicates that cell-cell adherent 
junction is one of the paramount factors required for the function of insulin-secreting β-cells. The 
importance of cell-cell adherent junction for β-cell survival and function is also verified by Kelly 
and colleagues (Kelly et al., 2010). PEG hydrogel was also fabricated to contain collagen type I, 
collagen type IV, fibrinogen, fibronectin, laminin, and vitronectin, and then used to encapsulate 
β-cells. β-cell survival significantly improved in ECM-containing PEG hydrogels compared to 
gels without ECM over 10 days. Insulin secretion was also enhanced in cells cultured in ECM-
containing hydrogels (Weber et al., 2008). The PEG/ECM-based scaffolds indeed contribute to 
the re-establishment of the islets-ECM interaction. Hiscox and his co-workers developed a 
device that allows islets to be cultured in between two layers of prevascularized collagen gels. 
These islets exhibited a higher level of viability and functionality compared to the free islets 
control (Hiscox et al., 2008). 
 While encapsulation of islet cells in a 3D scaffold provides protection against the immune 
cells and its antibodies, the diffusion of low molecular weight cytokines through the hydrogels 
remains to be a challenge. To overcome these issue, scaffold surface can be fabricated by coating 
the PEG-hydrogel with diffusible pro-inflammatory cytokines interleukin (IL)-1β receptor. This 
modification enabled maintainence of the viability of encapsulated islet cells and function as a 
glucose-stimulated insulin secretion after the exposure of different cytokines (Su et al., 2010). 
Another strategy to make a better 3D scaffold is to inhibit TNF receptor 1 activation by 
scafolding PEG-diacrylate hydrogels coated with TNF receptor 1. As a result, this modified 
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hydrogel not only preserved islet insulin content, but also reduced mRNA of inducible nitric 
oxide synthase and IL-6 in pancreases in experimental animals (Wang et al., 2002). 
Nevertheless, impaired oxygen diffusion within a 3D scaffold hinders the wide use of scaffold 
for islet cell expansion. In particular normoxia, or higher oxygen tension, promotes islet β-cell 
development from progenitor cells and increases β-cell viability (Fraker et al., 2007; Pedraza, 
2012; Skiles, 2013). As β-cells consume large amounts of oxygen during insulin secretion (Sato 
et al., 2011), studies have shown that islet aggregates may suffer from hypoxia proportional to 
the radial distance inward, leading to the cell necrosis and apoptosis as well as activation of 
anaerobic metabolism (Cantley et al., 2010). This issue may be overcome by culturing islet 
aggregates in an oxygenated system (Wu et al., 1999). Recently, an oxygenator made from 
polydimethylsiloxane (PDMS)/calcium peroxide enhanced the mouse MIN6 cell proliferation 
and insulin secretion for three weeks under hypoxic culture conditions (Pedraza et al., 2012). The 
oxygenating strategy is particularly promising because islet cells are usually sensitive to 
chemical compounds such as catalysts or hydrogen peroxide. To overcome the limitation of 
nutrient transport in a conventional cell culture dish, mouse β-cells were cultured in suspension 
in a stirred spinner flask. This bioreactor culture helped proliferation and increased sizes of cell 









CHAPTER 2  
2. ENHANCED PANCREATIC β-CELL PROLIFERATION AND FUNCTIONALITY  
2.1 INTRODUCTION 
Pancreatic β-cells are considered as one of the most important cells in the islets of 
Langerhans in the endocrine tissue of the pancreas. These cells are responsible for insulin 
production in response to blood glucose level. Driven by the urgent need to treat patients 
suffering from diabetes, intensive efforts have been made to create biologically functional islet 
tissues that can be used to replace diseased islets and regenerate a healthy tissue based on cell 
therapy. 
One of the main challenges remaining in adult pancreatic β-cell therapy is the extreme low 
proliferation rate which is approximately 01.-0.3% a day in aged adult mice and minimum 
replication in adult human (Ribaux et al., 2007). Fortunately, It is now well known that β-cell 
mass expansion can occur in early postnatal life, pregnancy, and animal models which have been 
genetically modulated (Buteau et al., 2004; Rieck & Kaestner, 2010). For this reason, it is 
important to fully understand the molecular mechanisms that can enhance functional pancreatic 
β-cell proliferation in a suitable environment for in vitro production. 
Adult human islets are surrounded by an incomplete capsule composed of a single layer of 
fibroblasts and collagen fibers. Additional matrix protein is attached to this capsule, which is 
known as the periinsular basement membrane (BM). Mechanical and chemical signaling 
interactions between cells and ECM are known to regulate several physiological aspects 
including: survival (Nagata et al., 2002), proliferation (Beattie et al., 1996), and insulin secretion 
in islets (Kaido et al., 2006). In living tissue, cells synthesize ECM components and deposit them 
to form a niche. Basement membrane usually has a mixture of pores (~ 72nm), riges, and fibers 
(~77nm in diameter) (Abrams et al., 2000). They separate tissue from each other allowing cells 
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to develop their polarized morphology. Sequentially, the roughness of a substrate and the porous 
structure are both essential for restoring the in vivo niche equilibrium. In addition, the 
impermeability of the substrate prevents cells from taking or secreting signaling molecules and 
nutrient from both basal and apical surfaces. Thus, membrane substrate has been used in growing 
various types of cells in the past (Grobstein, 1953). Nanostructured surfaces are fabricated by 
dispensing prepolymer (PUA) on a supporting polyethylene terephthalate (PET) film, forming a 
surface conformal contact with the cells. These nanostructured surfaces found to be able 
significantly enhance osteogenesis of human mesenchymal stem cells (hMSCs) (You et al., 
2010). However, the use of these membrane substrates on promoting the proliferation and insulin 
secretion of adult pancreatic beta cells has not yet been explored.  
Mouse insulinoma 6 (MIN6) cells are cell line originated from a transgenic C57BL/6 mouse 
insulinoma expressing an insulin-promoter/T-antigen construct, forming an islets like clusters 
(Skelin, Rupnik, & Cencic, 2010). In addition, these cells express GLUT-2 and glucokinase and 
respond to glucose within the physiological range in the presence of nicotinamide (Vit B3) 
(Miyazaki et al., 1990). In this study, we intend to determine whether a porous and permeable 
membrane substrate provides better tissue niche for pancreatic β-cells proliferation and insulin 
secretion. In addition, the possible signaling molecules that are responsible in enhancing 
pancreatic β-cell growth and functionality were examined as well.    
2.2 MATERIAL AND METHODS 
2.2.1. Cell culture and cell viability assay  
Mouse MIN6 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 25 mmol/L glucose, 2mM L-glutamine, and 2mM sodium pyruvate (Corning). The 
medium was supplemented with 15% fetal bovine serum (FBS) (ATCC), 10 mmol/mL 
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nonessential amino acids (NEAA), 50 mg/L streptomycin and 75 mg/L penicillin sulfate, and 
equilibrated with 5% CO2 and 95% air at 37ºC. The medium was replaced after each forty eight 
hours. For passage, MNI6 cells were treated with cold Dulbecco's Phosphate Buffered Saline 
(DPBS) without calcium and magnesium (Corning) to wash out the serum, and then cells were 
detached by using 0.05% Trypsin/0.53 mM EDTA in HBSS without Ca+2 and Mg+2 (Corning) 
for 5 minutes at 37ºC., Cells were centrifuged at 1400 RPM (300 RCF) for 5 minutes at room 
temperature. New DMEM was added to the cell pellet to re-suspend cells. Cells were splits at 
ratio of 1:3-1:5 every 7 days. The cells used in this study were at passage 20- 28 (Cheng et al., 
2012).  
Polyester (PE) (pore size: 0.4 μm) and polyethylene terephthalate (PET) (pore size: 1 μm) 
membranes were obtained from Millipore and Corning. The membrane substrates were placed in 
a six-well plate and seeded with 130,000 cells/ cm2 MIN6 cells in the DMEM medium. Cells 
seeded in a six-well tissue culture plate (TCP) was used as control. The viability of the MIN6 
was determined at indicated time points by using trypan blue staining assay after detaching the 
cells from culture plate using trypsin-EDTA.  The experiments were performed independently 
for four times. 
 
2.2.2 RNA extraction, quantification, and cDNA synthesis 
 At day eight, the cells were harvested to detect gene expression in cells grown on 
membrane substrates. Total RNA was isolated from the cells using RNA extraction kit (Qiagen). 
Synergy MX microplate reader (BioTek) was used to measure the RNA concentration. Genomic 
DNA was eliminated during RNA purification using DNase kit (Promega). 1 µg RNA was 
synthesized to cDNA in a reverse transcription reaction using RT kit (Applied Biosystems). The 
thermo cycler was programed as follows: 25°C for 10 minutes, 37°C for 2 hours, 85°C for 5 
20 
 
minutes and 4°C holding temperature. The resultant cDNA was stored at-80°C for further 
experiments.     
 
2.2.3 Gene expression 
Gene expression was carried out by using DNA polymerase (Biolabs) and detected by qRT-PCR 
using thermal cycling (Eppendorf) after RT reaction. qPCR was performed in 20 ul reaction 
volume (100 ng of cDNA/ reaction). A control assay was performed to ensure the absence of 
genomic DNA contamination in the qRT-PCR. The following primer pairs were used for 
characterization of mRNA expression. Insulin II forward: 5’ 
TAGTGACCAGCTATAATCAGAG 3’, Insulin II reverse: 5’ ACGCCAAGGTCTGAAGGTCC 
3’ (288bp), β-actin forward: 5’ ACGGCCAAGTCATCACTATTG 3’, β-actin reverse: 5’ 
AGCCACCGATCCACACAGA   3’ (300bp). The thermo cycler was programed as follows: 
95°C for 10 minutes, 40 cycles of denaturation at 95°C for 15 seconds, and annealing/extension 
at 60°C for 1 minute. The relative expression of insulin gene was normalized against β-actin. 
Quantification was performed using the comparative threshold cycle ΔΔCt method to calculate 
the fold changes between the TCP, PE, and PET samples. 
 
2. 2.4 PCR array for apoptosis receptors gene expression 
 Total RNA (2µg) was reverse transcribed in a 20µl reaction mixture using RT² First 
Strand Kit (Qiangen). The cDNA was subjected to gene array plate to examine the expression of 
eighty-four genes that are involved in the apoptotic pathway. All cDNA was used for qRT-PCR 
on the MicroAmp™Optical 96-well reaction plate system. The total reaction mix consists of 
1339 µl RNase-free water,1350 µl RT
2 
SYBR Green Mastermix (2X), and 20 µl cDNA sample. 
A 25 µl were loaded to each well of the 96-well plate. Gene expression detection was done by 
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qRT-PCR using thermal cycling. Apoptosis gene expression array plate (Qiangen) is shown in 
Table 2.1. The thermocycler was programed as follows: 95°C for 10 minutes, 40 cycles of 
denaturation at 95°C for 15 seconds, and annealing/extension at 60°C for 1 minute. The relative 
expression of each gene was normalized against β-actin. Quantification was performed using the 
comparative threshold cycle ΔΔCt method and calculating the fold changes between the TCP and 
PET samples. 
 
2. 2. 5 Statistical analysis  
All data shown are Mean±SD of three runs. Student’s t-test using two-tailed algorithm 
was calculated and p-values≤0.05 were considered statistically significant.   
 
2.3 RESULTS AND DISCUSSION  
2.3.1 Enhanced pancreatic β-cells proliferation by porous-structured substrates 
To examine whether or not a porous membrane substrate can provide better culture 
environment for β-cell proliferation, β-cells were seeded on a porous PE and PET membrane 
substrate, respectively. Cell grown on a conventional tissue culture polystyrene plate (TCP) 
served as a control for comparison. As shown in Fig. 2.1D, β-cells grew faster on PET membrane 
compared with cells cultured on TCP. The cell doubling time was 38.6±0.5 h when cultured on 
PET membrane with pore size of 1µm; while it was 64.7±0.4 h when cell cultured on TCP plate 
and 62±0.4 h when cultured on PE membrane. Moreover, β-cells tend to form larger colonies on 
the PET membrane substrate compared to that of TCP plates (Figure 2.1 A-C). These 
experimental results suggested that the topographical and chemical properties of a membrane 
substrate considerably influence β-cell proliferation.   
2.3.2 Insulin gene expression level in pancreatic β-cells grown on membrane substrates 
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Having verified β-cell proliferation, we next examined whether or not membrane 
substrates improve cell functionality. Insulin gene expression level for cells grown on PE and 
PET was detected through qRT-PCR assay and compared with those grown on TCP cultures. As 
shown on Fig. 2.2, the insulin gene expression in cells cultured on PET membrane was thirteen-
fold higher than those on TCP cultures with p-value 0.02. However, the levels of insulin gene 
expression are similar in cells grown on PE and TCP. The experimental result indicates a 
significance enhancement in the insulin gene expression when cells are grown on PET 
membrane substrate.        
 
2.3.3 Regulation of apoptosis pathway in pancreatic β-cells grown on PET membrane 
substrate  
To investigate the mechanism of the enhanced cell proliferation and insulin production 
using PET membrane substrate, the expression profile of eighty-four genes that are involved in 
the apoptotic pathway were measured by qRT-PCR.  
Apoptosis pathway is well known pathway to explain cell proliferation and programed 
cell death mechanism. In this process, unwanted cells or any detrimental cells will be disposed to 
prevent the development of an inflammatory response. There are two distinct pathways for 
apoptosis, an “extrinsic” and an “intrinsic” pathway (Parrish et al., 2013). In both pathways, 
signaling result in the activation of a family of Cys (cysteine) proteases, named Caspases, that 
act in a proteolytic cascade dismantle and remove the dying cell (Parrish et al., 2013). Extrinsic 
pathway is initiated by the activation of death receptors, such as Fas, Apo2/Apo3 and TNFR1, 
through its ligands FasL, Apo2L/Apo3L, and TNFα subsequently. These cell surface receptors 
belong to the superfamily of tumor necrosis factor receptors (TNFR), which are characterized by 
Cys-rich extracellular domain and a homologues intracellular domain known as death domain 
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(DD). Adapter molecule containing DD interacts with death receptor and transmits the apoptotic 
signals to initiator pro-caspases and results in its activation through a proteolytic cleavage.  
In this study, the PET substrate is subjected to characterize the signaling pathway 
involved in enhancing cell proliferation and inhibiting cell apoptosis. Results showed that several 
genes are up regulated as shown in Figure 2.3, whereas other genes were down-regulated (Fig 
2.4). As mentioned previously, Insulin stimulate Akt signaling pathway which are responsible of 
generating cell signals for cell replication. In addition, several anti-apoptotic genes showed a 
significant enhancement in PET culture, such as Bcl2, Bcl2l1, and Bcl2l2. These genes prevent 
apoptosis signaling through competing with Bad and Bax gene in binding to mitochondrial 
membrane. In addition, TNF plays dual roles in the cell proliferation process. Next to its ability 
to induce apoptosis, it has the ability to transduce cell survival signals by activating the 
transcription factor NF-kappa B.It has been observed that when the initial plasma membrane 
bound complex (complex I) consisting of tumor necrosis factor receptor (TNFR1), the TNFR-
associated death domain (TRADD), the receptor interacting protein (RIP1), and TNF receptor-
associated factor-2 (TRAF2), activation of NF-kappa B complex I is formed (Figure 2.5) 
(Micheau & Tschopp, 2003). As a result, complex II consisting of TRADD and RIP1 bind with 
FADD and caspase-8 failed to assemble by NF-kappa B feedback inhibition (Natoli et al., 1997). 
Figure 2.4 showed a significant down regulation of caspase 3, caspase 6, caspase 7, caspase 8, 
caspase 9, Bax, Bad, Bak1, Bid, Fadd, and Apaf1 have occurred in the cells growing on the PET 
membrane, indicating that the membrane offers better niche by inducing survival signals and 





2.4 CONCLUSION AND FUTURE WORK  
In this work, the down regulation of apoptosis related genes detected in pancreatic β-cells 
supports our hypothesis of using porous membrane substrates to improve the proliferation of 
pancreatic β-cells. 
Several experiments can be conducted in the future. mRNA expression level may not 
correlate to the protein expression level. Thus, it is necessary to confirm protein expression level 
by Western blotting. In addition, the regulation mechanism remains unclear and need more 
investigation. Finally, detecting the expression level of adhesion molecules will give more 
detailed information on the cell adhesion mechanism involved in cell-PET attachment. This 
could help for further improvement to generate a better biodegradable material to be used in the 
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Figure 2.1 β-cell proliferation on various substrates.β-cells were seeded onto tissue culture 
polystyrene plate (TCP) (A), 0.4 µm PE (B), and 1µm PET (C) membrane substrate in DMEM 
medium. The micrographic images of cell attachment were taken at day2 after seeding. Scale bar 
100 µm. (D) Time courses of β-cell proliferation on various substrates. Data were presented as 
mean± SD. All experiments were carried out three times. * PE p-value 0.7, PET p-value 0.03. 
 





















Figure 2.2 Insulin gene expression was detected in cells grown on various membrane substrates 
at day eight compared to TCP and normalized by β-actin expression. Data were presented as 


























Gene ID Fold change p-value 
Akt 9.5±0.9 0.047 
BcL2 5.7±1.8 0.012 
Bcl2l1 2.8±0.5 0.011 
Bcl2l2 2.7±1.4 0.029 
Mpk1 8.2±2.3 0.011 
Tnf 8.4±1.8 0.034 
Traf2 4.1±2.5 0.015 
Tnfrsf1a 6.5±1.50 0.028 
 
Figure 2.3 Relative up regulated gene expression levels in cells grown on PET membrane 
substrate at day eight compared to TCP. Data were presented as mean±SD. All experiments were 
carried out three times and normalized by β-actin gene expression. Abbreviations: Akt, 
Thymoma viral proto-oncogene 1; BCL2, B-cell leukemia/lymphoma 2; Bcl2l1, Bcl2-like 1; 
Bcl2l2, Bcl2-like 2; Mapk1, Mitogen-activated protein kinase 1; Tnf, Tumor necrosis factor; 
Traf2; Tnf receptor-associated factor 2; Tnfrsf1a, Tumor necrosis factor receptor superfamily, 


















Gene ID Fold change p-value 
Apaf1 0.053±0.014 0.0046 
Bad 0.024±0.016 0.024 
Bax 0.031±0.023 0.016 
Bak1 0.042±0.013 0.0023 
Bid 0.026±0.014 0.001 
Casp3 0.026±0.017 0.001 
Casp6 0.037±0.008 0.01 
Casp7 0.020±0.016 0.0001 
Casp8 0.021±0.012 0.015 
Casp9 0.024±0.011 0.012 
Fadd 0.053±0.013 0.011 
 
Figure 2.4 Relative down regulated gene expression levels in cells grown on PET membrane 
substrate at day eight compared to TCP. Data were presented as mean±SD. All experiments were 
carried out three times and normalized by β-actin gene expression. Abbreviations: Apaf1, 
Apoptotic peptidase activating factor 1; Bad, BCL2-associated agonist of cell death; Bax, Bcl2-
associated X protein; Bak1, BCL2-antagonist/killer 1; Bid, BH3 interacting domain death 
agonist; Casp3, Caspase 3; Casp 6, Caspase 6; Casp7, Caspase 7; Casp8, Caspase 8; Casp 9, 



















Abrams, G. A., Goodman, S. L., Nealey, P. F., Franco, M., & Murphy, C. J. (2000). Nanoscale 
topography of the basement membrane underlying the corneal epithelium of the rhesus 
macaque. Cell and Tissue Research, 299(1), 39-46.  
Abrams, G. A., Schaus, S. S., Goodman, S. L., Nealey, P. F., & Murphy, C. J. (2000). Nanoscale 
topography of the corneal epithelial basement membrane and descemet's membrane of the 
human. Cornea, 19(1), 57-64.  
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000). The c-jun NH(2)-terminal 
kinase promotes insulin resistance during association with insulin receptor substrate-1 and 
phosphorylation of ser(307). The Journal of Biological Chemistry, 275(12), 9047-9054.  
Ahrén, B. (2000). Autonomic regulation of islet hormone secretion--implications for health and 
disease. Diabetologia, 43(4), 393-410.  
Alonso, L. C., Yokoe, T., Zhang, P., Scott, D. K., Kim, S. K., O'Donnell, C.,P., & Garcia-Ocaña, 
A. (2007). Glucose infusion in mice: A new model to induce beta-cell replication. Diabetes, 
56(7), 1792-1801.  
Alwan, A. (2011). In Alwan A. (Ed.), Global status report on noncommunicable diseases 2010. 
Geneva; Switzerland: World Health Organization.  
Anderson, M. S., & Bluestone, J. A. (2005). THE NOD MOUSE: A model of immune 
dysregulation. Annual Review of Immunology, 23(1), 447-485.  
Beattie, G. M., Rubin, J. S., Mally, M. I., Otonkoski, T., & Hayek, A. (1996). Regulation of 
proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, 
hepatocyte growth factor, and cell-cell contact. Diabetes, 45(9), 1223-1228.  
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001). Islet beta 
cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, 
hyperplasia, and hyperinsulinemia. The Journal of Clinical Investigation, 108(11), 1631-
1638.  
Bernal-Mizrachi, E., Wice, B., Inoue, H., & Permutt, M. A. (2000). Activation of serum response 
factor in the depolarization induction of egr-1 transcription in pancreatic islet beta-cells. The 
Journal of Biological Chemistry, 275(33), 25681-25689.  
Bernard, A. B., Lin, C., & Anseth, K. S. (2012). A microwell cell culture platform for the 
aggregation of pancreatic beta-cells. Tissue Engineering Part C-Methods, 18(8), 583-592. 
doi:10.1089/ten.tec.2011.0504  
Bernard, C., Ktorza, A., Saulnier, C., & Berthault, M. F. (1999). Neogenesis vs. apoptosis as 
main components of pancreatic beta cell mass changes in glucose-infused normal and mildly 
diabetic adult rats. FASEB Journal : Official Publication of the Federation of American 
Societies for Experimental Biology, 13(10), 1195-1205.  
32 
 
Bosco, D., Meda, P., Halban, P. A., & Rouiller, D. G. (2000). Importance of cell-matrix 
interactions in rat islet beta-cell secretion in vitro: Role of alpha6beta1 integrin. Diabetes, 
49(2), 233-243.  
Bruning, J., Winnay, J., BonnerWeir, S., Taylor, S., Accili, D., & Kahn, C. (1997). Development 
of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. 
Cell, 88(4), 561-572. doi:10.1016/S0092-8674(00)81896-6  
Buteau, J., El-Assaad, W., Rhodes, C. J., Rosenberg, L., Joly, E., & Prentki, M. (2004). 
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia, 47(5), 806-815.  
Buteau, J., Foisy, S., Joly, E., & Prentki, M. (2003). Glucagon-like peptide 1 induces pancreatic 
beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes, 
52(1), 124-132.  
Cantley, J., Grey, S. T., Maxwell, P. H., & Withers, D. J. (2010). The hypoxia response pathway 
and ß-cell function. Diabetes, Obesity & Metabolism, 12 Suppl 2, 159-167. 
doi:10.1111/j.1463-1326.2010.01276.x  
Cantley, J., Selman, C., Shukla, D., Abramov, A. Y., Forstreuter, F., Esteban, M. A., . . . 
Withers, D. J. (2009). Deletion of the von hippel-lindau gene in pancreatic beta cells impairs 
glucose homeostasis in mice. The Journal of Clinical Investigation, 119(1), 125-135. 
doi:10.1172/JCI26934  
Centers for Disease Control and Prevention. (2011). National Diabetes Fact Sheet: National 
Estimates and General Information on Diabetes and Prediabetes in the United States,  
Chang-Chen, K., Mullur, R., & Bernal-Mizrachi, E. (2008). Beta-cell failure as a complication of 
diabetes. Reviews in Endocrine & Metabolic Disorders, 9(4), 329-343. doi:10.1007/s11154-
008-9101-5  
Cheng, K., Delghingaro-Augusto, V., Nolan, C. J., Turner, N., Hallahan, N., Andrikopoulos, S., 
& Gunton, J. E. (2012). High passage MIN6 cells have impaired insulin secretion with 
impaired glucose and lipid oxidation. Plos One, 7(7), 1-12. 
doi:10.1371/journal.pone.0040868 
Christensen, M., Vedtofte, L., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2011). Glucose-dependent 
insulinotropic polypeptide: A bifunctional glucose-dependent regulator of glucagon and 
insulin secretion in humans. Diabetes, 60(12), 3103-3109. doi:10.2337/db11-0979  
Da, S. X., Leclerc, I., Varadi, A., Tsuboi, T., Moule, S. K., & Rutter, G. A. (2003). Role for 
AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene 
expression. The Biochemical Journal, 371, 761-774.  
Dai, C., Li, Y., Yang, J., & Liu, Y. (2003). Hepatocyte growth factor preserves beta cell mass 
and mitigates hyperglycemia in streptozotocin-induced diabetic mice. The Journal of 
Biological Chemistry, 278(29), 27080-27087.  
33 
 
Daneman, D. (2006). Type 1 diabetes. The Lancet, 367(9513), 847-858. doi:10.1016/S0140-
6736(06)68341-4  
Drucker, D. J. (2006). The biology of incretin hormones. Cell Metabolism, 3(3), 153-165.  
Drucker, D. J. (2007). The role of gut hormones in glucose homeostasis. The Journal of Clinical 
Investigation, 117(1), 24-32.  
Eberhard, D., & Lammert, E. (2009). The pancreatic ß-cell in the islet and organ community. 
Current Opinion in Genetics & Development, 19(5), 469-475. 
doi:10.1016/j.gde.2009.07.003  
Fan, R., Li, X., Gu, X., Chan, J. C. N., & Xu, G. (2010). Exendin-4 protects pancreatic beta cells 
from human islet amyloid polypeptide-induced cell damage: Potential involvement of AKT 
and mitochondria biogenesis. Diabetes, Obesity & Metabolism, 12(9), 815-824. 
doi:10.1111/j.1463-1326.2010.01238.x  
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., . . . Perfetti, R. 
(2003). Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness 
of freshly isolated human islets. Endocrinology, 144(12), 5149-5158.  
Fraker, C. A., Alvarez, S., Papadopoulos, P., Giraldo, J., Gu, W., Ricordi, C., . . . Domínguez-
Bendala, J. (2007). Enhanced oxygenation promotes beta-cell differentiation in vitro. Stem 
Cells (Dayton, Ohio), 25(12), 3155-3164.  
Freemark, M., Avril, I., Fleenor, D., Driscoll, P., Petro, A., Opara, E., . . . Kelly, P. A. (2002). 
Targeted deletion of the PRL receptor: Effects on islet development, insulin production, and 
glucose tolerance. Endocrinology, 143(4), 1378-1385.  
Fridlyand, L. E., & Philipson, L. H. (2004). Does the glucose-dependent insulin secretion 
mechanism itself cause oxidative stress in pancreatic beta-cells? Diabetes, 53(8), 1942-
1948.  
Gahr, S., Merger, M., Bollheimer, L. C., Hammerschmied, C. G., Schölmerich, J., & Hügl, ,S.R. 
(2002). Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells 
particularly in the presence of subphysiological glucose concentrations. Journal of 
Molecular Endocrinology, 28(2), 99-110.  
García-Ocaña, A., Vasavada, R. C., Cebrian, A., Reddy, V., Takane, K. K., López-Talavera, 
,J.C., & Stewart, A. F. (2001). Transgenic overexpression of hepatocyte growth factor in the 
beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes, 
50(12), 2752-2762.  
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., . . . 
Coleman, K. G. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild 
growth deficiency in mice lacking Akt2/PKB beta. The Journal of Clinical Investigation, 
112(2), 197-208.  
34 
 
Gasparo, M. D., Milner, G. R., Norris, P. D., & Milner, R. D. G. (1978). Effect of glucose and 
amino acids on foetal rat pancreatic growth and insulin secretion in vitro. Journal of 
Endocrinology, 77(2), 241-248.  
George, M., Ayuso, E., Casellas, A., Costa, C., Devedjian, J. C., & Bosch, F. (2002). Beta cell 
expression of IGF-I leads to recovery from type 1 diabetes. The Journal of Clinical 
Investigation, 109(9), 1153-1163.  
Grill, V. (2001). Overstimulation and beta-cell function. Diabetes, 50, S122.  
GROBSTEIN, C. (1953). Morphogenetic interaction between embryonic mouse tissues separated 
by a membrane filter. Nature, 172(4384), 869-870.  
Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y., . . . Kahn, C. R. 
(2005). Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet 
dysfunction in human type 2 diabetes. Cell, 122(3), 337-349.  
Harmon, J. S., Stein, R., & Robertson, R. P. (2005). Oxidative stress-mediated, post-translational 
loss of MafA protein as a contributing mechanism to loss of insulin gene expression in 
glucotoxic beta cells. The Journal of Biological Chemistry, 280(12), 11107-11113.  
Heit, J. J., Apelqvist, A. A., Gu, X., Winslow, M. M., Neilson, J. R., Crabtree, G. R., & Kim, S. 
K. (2006). Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. 
Nature, 443(7109), 345-349.  
Heit, J. J., Karnik, S. K., & Kim, S. K. (2006). Intrinsic regulators of pancreatic β-cell 
proliferation. Annual Review of Cell & Developmental Biology, 22(1), 311-338. 
doi:10.1146/annurev.cellbio.22.010305.104425  
Hiscox, A. M., Stone, A. L., Limesand, S., Hoying, J. B., & Williams, S. K. (2008). An islet-
stabilizing implant constructed using a preformed vasculature. Tissue Engineering.Part A, 
14(3), 433-440. doi:10.1089/tea.2007.0099  
Hogg, J., Han, V. K., Clemmons, D. R., & Hill, D. J. (1993). Interactions of nutrients, insulin-
like growth factors (IGFs) and IGF-binding proteins in the regulation of DNA synthesis by 
isolated fetal rat islets of langerhans. The Journal of Endocrinology, 138(3), 401-412.  
Holz, G. G., Leech, C. A., Heller, R. S., Castonguay, M., & Habener, J. F. (1999). cAMP-
dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in 
pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone 
glucagon-like peptide-1-(7-37). The Journal of Biological Chemistry, 274(20), 14147-
14156.  
Hoorens, A., Van, d. C., Klöppel, G., & Pipeleers, D. (1996). Glucose promotes survival of rat 
pancreatic beta cells by activating synthesis of proteins which suppress a constitutive 
apoptotic program. The Journal of Clinical Investigation, 98(7), 1568-1574.  
35 
 
Huei-Min Lin, Ji-Hyeon Lee, Yadav, H., Kamaraju, A. K., Liu, E., Zhigang, D., . . . Rane, S. G. 
(2009). Transforming growth factor-β/Smad3 signaling regulates insulin gene transcription 
and pancreatic islet β-cell function. Journal of Biological Chemistry, 284(18), 12246-12257. 
doi:10.1074/jbc.M805379200  
Issa, C. M., & Azar, S. T. (2012). Possible role of GLP-1 and its agonists in the treatment of type 
1 diabetes mellitus. Current Diabetes Reports, 12(5), 560-567. doi:10.1007/s11892-012-
0291-6  
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., . . . 
Montminy, M. (2003). cAMP promotes pancreatic beta-cell survival via CREB-mediated 
induction of IRS2. Genes & Development, 17(13), 1575-1580.  
Juliano, R. L., & Haskill, S. (1993). Signal transduction from the extracellular matrix. The 
Journal of Cell Biology, 120(3), 577-585.  
Kaido, T., Yebra, M., Cirulli, V., Rhodes, C., Diaferia, G., & Montgomery, A. M. (2006). Impact 
of defined matrix interactions on insulin production by cultured human beta-cells: Effect on 
insulin content, secretion, and gene transcription. Diabetes, 55(10), 2723-2729.  
Kaiser, G., Gerst, F., Michael, D., Berchtold, S., Friedrich, B., Strutz-Seebohm, N., . . . Ullrich, 
S. (2013). Regulation of forkhead box O1 (FOXO1) by protein kinase B and 
glucocorticoids: Different mechanisms of induction of beta cell death in vitro. Diabetologia,  
Kaneto, H., Xu, G., Fujii, N., Kim, S., Bonner-Weir, S., & Weir, G. C. (2002). Involvement of c-
jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. 
The Journal of Biological Chemistry, 277(33), 30010-30018.  
Kawamori, D., Kaneto, H., Nakatani, Y., Matsuoka, T., Matsuhisa, M., Hori, M., & Yamasaki, 
Y. (2006). The forkhead transcription factor Foxo1 bridges the JNK pathway and the 
transcription factor PDX-1 through its intracellular translocation. The Journal of Biological 
Chemistry, 281(2), 1091-1098.  
Kawasaki, E., Abiru, N., & Eguchi, K. (2004). Prevention of type 1 diabetes: From the view 
point of beta cell damage. Diabetes Research and Clinical Practice, 66 Suppl 1, S27-S32.  
Kelly, C., Parke, H. G., McCluskey, J. T., Flatt, P. R., & McClenaghan, N. H. (2010). The role of 
glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell 
function in heterotypic pseudoislets. Diabetes/metabolism Research and Reviews, 26(7), 
525-533. doi:10.1002/dmrr.1111  
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W. H., Wright, C. V. E., . . . Accili, D. 
(2002). The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of 
pancreatic Β cell growth. Journal of Clinical Investigation, 110(12), 1839.  
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985). Islet pathology and 
the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Survey and Synthesis of 
Pathology Research, 4(2), 110-125.  
36 
 
Kobayashi, M., Kikuchi, O., Sasaki, T., Kim, H., Yokota-Hashimoto, H., Lee, Y., . . . Kitamura, 
T. (2012). FoxO1 as a double-edged sword in the pancreas: Analysis of pancreas- and 
[beta]-cell-specific FoxO1 knockout mice. American Journal of Physiology, 302(5), E603.  
Krishnamurthy, M., Li, J., Al-Masri, M., & Wang, R. (2008). Expression and function of 
alphabeta1 integrins in pancretic beta (INS-1) cells. Journal of Cell Communication and 
Signaling, 2(3-4), 67-79. doi:10.1007/s12079-008-0030-6  
Kulkarni, R. N., Brüning, ,J.C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. 
(1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an 
insulin secretory defect similar to that in type 2 diabetes. Cell, 96(3), 329-339.  
Kulkarni, R. N. (2005). New insights into the roles of insulin/IGF-I in the development and 
maintenance of beta-cell mass. Reviews in Endocrine & Metabolic Disorders, 6(3), 199-
210.  
Kushner, J. A., Ye, J., Schubert, M., Burks, D. J., Dow, M. A., Flint, C. L., . . . White, M. F. 
(2002). Pdx1 restores beta cell function in Irs2 knockout mice. The Journal of Clinical 
Investigation, 109(9), 1193-1201.  
Lawrence, M. C., Bhatt, H. S., Watterson, J. M., & Easom, R. A. (2001). Regulation of insulin 
gene transcription by a ca(2+)-responsive pathway involving calcineurin and nuclear factor 
of activated T cells. Molecular Endocrinology (Baltimore, Md.), 15(10), 1758-1767.  
Lawrence, M. C., Bhatt, H. S., & Easom, R. A. (2002). NFAT regulates insulin gene promoter 
activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. 
Diabetes, 51(3), 691-698.  
Li, Y., Cao, X., Li, L., Brubaker, P. L., Edlund, H., & Drucker, D. J. (2005). Beta-cell Pdx1 
expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of 
glucagon-like peptide-1. Diabetes, 54(2), 482-491.  
Lin, C., & Anseth, K. S. (2011). Cell-cell communication mimicry with poly(ethylene glycol) 
hydrogels for enhancing beta-cell function. Proceedings of the National Academy of 
Sciences of the United States of America, 108(16), 6380-6385.  
Lingohr, M. K., Dickson, L. M., McCuaig, J. F., Hugl, S. R., Twardzik, D. R., & Rhodes, C. J. 
(2002). Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or 
EGF, augments pancreatic beta-cell proliferation. Diabetes, 51(4), 966-976.  
Lock, L. T., Laychock, S. G., & Tzanakakis, E. S. (2011). Pseudoislets in stirred-suspension 
culture exhibit enhanced cell survival, propagation and insulin secretion. Journal of 
Biotechnology, 151(3), 278-286. doi:10.1016/j.jbiotec.2010.12.015  
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H., Spinas, G. A., . . . Donath, 
M. Y. (2002). Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity 
in human pancreatic islets. The Journal of Clinical Investigation, 110(6), 851-860.  
37 
 
Matsumoto, K., & Nakamura, T. (1996). Emerging multipotent aspects of hepatocyte growth 
factor. Journal of Biochemistry, 119(4), 591-600.  
McKinnon, C. M., & Docherty, K. (2001). Pancreatic duodenal homeobox-1, PDX-1, a major 
regulator of beta cell identity and function. Diabetologia, 44(10), 1203-1214.  
Merani, S., & Shapiro, A. M. J. (2006). Current status of pancreatic islet transplantation. Clinical 
Science (London, England: 1979), 110(6), 611-625.  
Micheau, O., & Tschopp, J. ü. (2003). Induction of TNF receptor I-mediated apoptosis via two 
sequential signaling complexes. Cell, 114(2), 181-190.  
Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., . . . Yamamura, K. 
(1990). Establishment of a pancreatic beta cell line that retains glucose-inducible insulin 
secretion: Special reference to expression of glucose transporter isoforms. Endocrinology, 
127(1), 126-132.  
 
Nagata, N., Iwanaga, A., Inoue, K., & Tabata, Y. (2002). Co-culture of extracellular matrix 
suppresses the cell death of rat pancreatic islets. Journal of Biomaterials Science -- Polymer 
Edition, 13(5), 579-590. doi:10.1163/15685620260178418  
Nakae, J., Biggs,William H.,,3rd, Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., 
& Accili, D. (2002). Regulation of insulin action and pancreatic beta-cell function by 
mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nature Genetics, 
32(2), 245-253.  
Natoli, G., Costanzo, A., Ianni, A., Templeton, D. J., Woodgett, J. R., Balsano, C., & Levrero, 
M. (1997). Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-
dependent pathway. Science (New York, N.Y.), 275(5297), 200-203.  
Nielsen, J. H. (2001). Regulation of beta-cell mass by hormones and growth factors. Diabetes, 
50, S25.  
Nikolova, G., Jabs, N., Konstantinova, I., Domogatskaya, A., Tryggvason, K., Sorokin, L., . . . 
Lammert, E. (2006). The vascular basement membrane: A niche for insulin gene expression 
and ß cell proliferation. Developmental Cell, 10(3), 397-405. 
doi:10.1016/j.devcel.2006.01.015  
Nir, T., Melton, D. A., & Dor, Y. (2007). Recovery from diabetes in mice by beta cell 
regeneration. The Journal of Clinical Investigation, 117(9), 2553-2561.  
Nobukini, T., & Thomas, G. (2004). The mTOR/S6K signalling pathway: The role of the 
TSC1/2 tumour suppressor complex and the proto-oncogene rheb. Novartis Foundation 
Symposium, 262, 148.  
Nyblom, H. K., Sargsyan, E., & Bergsten, P. (2008). AMP-activated protein kinase agonist dose 
dependently improves function and reduces apoptosis in glucotoxic beta-cells without 
38 
 
changing triglyceride levels. Journal of Molecular Endocrinology, 41(3), 187-194. 
doi:10.1677/JME-08-0006  
Nyblom, H. K., Thorn, K., Ahmed, M., & Bergsten, P. (2006). Mitochondrial protein patterns 
correlating with impaired insulin secretion from INS-1E cells exposed to elevated glucose 
concentrations. Proteomics, 6(19), 5193-5198.  
Ohsugi, M., Cras-Meneur, C., Zhou, Y., Bernal-Mizrachi, E., Johnson, J., Luciani, D., . . . 
Permutt, M. (2005). Reduced expression of the insulin receptor in mouse insulinoma 
(MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, 
insulin content, and secretion. Journal of Biological Chemistry, 280(6), 4992-5003. 
doi:10.1074/jbc.M411727200  
Ohsugi, M., Cras-Méneur, C., Zhou, Y., Warren, W., Bernal-Mizrachi, E., & Permutt, M. A. 
(2004). Glucose and insulin treatment of insulinoma cells results in transcriptional 
regulation of a common set of genes. Diabetes, 53(6), 1496-1508.  
Paris, M., Bernard-Kargar, C., Berthault, M., Bouwens, L., & Ktorza, A. (2003). Specific and 
combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in 
adult rats. Endocrinology, 144(6), 2717-2727.  
Park, S., Dong, X., Fisher, T. L., Dunn, S., Omer, A. K., Weir, G., & White, M. F. (2006). 
Exendin-4 uses Irs2 signaling to mediate pancreatic β cell growth and function. Journal of 
Biological Chemistry, 281(2), 1159-1168. doi:10.1074/jbc.M508307200  
Parnaud, G., Hammar, E., Ribaux, P., Donath, M. Y., Berney, T., & Halban, P. A. (2009). 
Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular 
matrix. Molecular Endocrinology (Baltimore, Md.), 23(8), 1264-1271. 
doi:10.1210/me.2009-0008  
Parrish, A. B., Freel, C. D., & Kornbluth, S. (2013). Cellular mechanisms controlling caspase 
activation and function. Cold Spring Harbor Perspectives in Biology, 5(6) 
doi:10.1101/cshperspect.a008672  
Parsons, J. A., Brelje, T. C., & Sorenson, R. L. (1992). Adaptation of islets of langerhans to 
pregnancy: Increased islet cell proliferation and insulin secretion correlates with the onset of 
placental lactogen secretion. Endocrinology, 130(3), 1459-1466.  
Pedraza, E., Coronel, M. M., Fraker, C. A., Ricordi, C., & Stabler, C. L. (2012). Preventing 
hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-
generating biomaterials. Proceedings of the National Academy of Sciences of the United 
States of America, 109(11), 4245-4250. doi:10.1073/pnas.1113560109  
Petrik, J., Pell, J. M., Arany, E., McDonald, T. J., Dean, W. L., Reik, W., & Hill, D. J. (1999). 
Overexpression of insulin-like growth factor-II in transgenic mice is associated with 
pancreatic islet cell hyperplasia. Endocrinology, 140(5), 2353-2363.  
39 
 
Pinkse, G. G. M., Bouwman, W. P., Jiawan-Lalai, R., Terpstra, O. T., Bruijn, J. A., & de Heer, 
E. (2006). Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance 
to apoptosis in islets of langerhans. Diabetes, 55(2), 312-317.  
Poitout, V., Olson, L. K., & Robertson, R. P. (1996). Chronic exposure of betaTC-6 cells to 
supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene 
transcription activator. The Journal of Clinical Investigation, 97(4), 1041-1046.  
Poitout, V., & Robertson, R. P. (2002). Minireview: Secondary beta-cell failure in type 2 
diabetes--a convergence of glucotoxicity and lipotoxicity. Endocrinology, 143(2), 339-342.  
Puri, S., Cano, D. A., & Hebrok, M. (2009). A role for von hippel-lindau protein in pancreatic 
beta-cell function. Diabetes, 58(2), 433-441. doi:10.2337/db08-0749  
Rane, S. G., Lee, J., & Lin, H. (2006). Transforming growth factor-beta pathway: Role in 
pancreas development and pancreatic disease. Cytokine & Growth Factor Reviews, 17(1-2), 
107-119.  
Ribaux, P., Ehses, J. A., Lin-Marq, N., Carrozzino, F., Boeni-Schnetzler, M., Hammar, E., . . . 
Halban, P. A. (2007). Induction of CXCL1 by extracellular matrix and autocrine 
enhancement by interleukin-1 in rat pancreatic {beta}-cells. Endocrinology, 148(11), 5582-
5590.  
Rieck, S., & Kaestner, K. H. (2010). Expansion of beta-cell mass in response to pregnancy. 
Trends in Endocrinology and Metabolism: TEM, 21(3), 151-158. 
doi:10.1016/j.tem.2009.11.001  
Robertson, R. P., & Harmon, J. S. (2006). Diabetes, glucose toxicity, and oxidative stress: A case 
of double jeopardy for the pancreatic islet beta cell. Free Radical Biology & Medicine, 
41(2), 177-184.  
Rutti, S., Sauter, N. S., Bouzakri, K., Prazak, R., Halban, P. A., & Donath, M. Y. (2012). In vitro 
proliferation of adult human beta-cells. Plos One, 7(4), 1-4. 
doi:10.1371/journal.pone.0035801  
Saltiel, A. R., & Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid 
metabolism. Nature, 414(6865), 799-806.  
Sato, Y., Endo, H., Okuyama, H., Takeda, T., Iwahashi, H., Imagawa, A., . . . Inoue, M. (2011). 
Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for 
insulin secretion in vitro. The Journal of Biological Chemistry, 286(14), 12524-12532. 
doi:10.1074/jbc.M110.194738  
Shalev, A., Pise-Masison, C., Radonovich, M., Hoffmann, S. C., Hirshberg, B., Brady, J. N., & 
Harlan, D. M. (2002). Oligonucleotide microarray analysis of intact human pancreatic islets: 
Identification of glucose-responsive genes and a highly regulated TGFbeta signaling 
pathway. Endocrinology, 143(9), 3695-3698.  
40 
 
Shapiro, A. J., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., . . . Rajotte, R. 
V. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a 
glucocorticoid-free immunosuppressive regimen. The New England Journal of Medicine, 
343(4), 230-238.  
Sharma, A., Olson, L. K., Robertson, R. P., & Stein, R. (1995). The reduction of insulin gene 
transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is 
associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Molecular 
Endocrinology (Baltimore, Md.), 9(9), 1127-1134.  
SJÖHOLM, Å. (1996). Diabetes mellitus and impaired pancreatic β-cell proliferation. Journal of 
Internal Medicine, 239(3), 211-220. doi:10.1046/j.1365-2796.1996.377740000.x  
Skelin, M., Rupnik, M., & Cencic, A. (2010). Pancreatic beta cell lines and their applications in 
diabetes mellitus research. Altex, 27(2), 105-113.  
Skiles, M. L., Wilder, N. B., Sahai, S., & Blanchette, J. O. (2013). Identifying HIF activity in 
three-dimensional cultures of islet-like clusters. Italy: Wichtig Editore. 
doi:10.5301/IJAO.5000193  
Shao, W., Wang, Z., Ip ,W., Chiang, YT., Xiong, X., Chai. T., Xu, C., Wang, Q., & Jin. T 
. (2013). GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin induced 
diabetes mice and activates PKA-β-catenin signaling in beta-cells in vitro. Am J Physiol 
Endocrinol Metab, doi:10.1152/ajpendo.00600.2012  
Su, J., Hu, B., Lowe, W. L., Kaufman, D. B., & Messersmith, P. B. (2010). Anti-inflammatory 
peptide-functionalized hydrogels for insulin-secreting cell encapsulation 
doi:10.1016/j.biomaterials.2009.09.045  
Suarez-Pinzon, W., Marcoux, Y., Ghahary, A., & Rabinovitch, A. (2002). Gene transfection and 
expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects 
beta-cells in syngeneic islet grafts from autoimmune destruction. Cell Transplantation, 
11(6), 519-528.  
Swenne, I. (1982). The role of glucose in the in vitro regulation of cell cycle kinetics and 
proliferation of fetal pancreatic B-cells. Diabetes, 31(9), 754-760.  
Tanabe, K., Liu, Z., Patel, S., Doble, B. W., Li, L., Cras-Méneur, C., . . . Permutt, M. A. (2008). 
Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of 
insulin resistance. Plos Biology, 6(2), e37-e37. doi:10.1371/journal.pbio.0060037  
Trümper, A., Trümper, K., Trusheim, H., Arnold, R., Göke, B., & Hörsch, D. (2001). Glucose-
dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic 
signaling. Molecular Endocrinology (Baltimore, Md.), 15(9), 1559-1570.  
Tsuboi, T., da, S. X., Holz, G. G., Jouaville, L. S., Thomas, A. P., & Rutter, G. A. (2003). 
Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP 
synthesis in pancreatic MIN6 beta-cells. The Biochemical Journal, 369, 287-299.  
41 
 
Tuttle, R. L., Gill, N. S., Pugh, W., Lee, J. P., Koeberlein, B., Furth, E. E., . . . Birnbaum, M. J. 
(2001). Regulation of pancreatic beta-cell growth and survival by the serine/threonine 
protein kinase Akt1/PKBalpha. Nature Medicine, 7(10), 1133-1137.  
Tyrberg, B., Eizirik, D. L., Hellerström, C., Pipeleers, D. G., & Andersson, A. (1996). Human 
pancreatic beta-cell deoxyribonucleic acid-synthesis in islet grafts decreases with increasing 
organ donor age but increases in response to glucose stimulation in vitro. Endocrinology, 
137(12), 5694-5699.  
Unger, R. H., Zhou, Y. T., & Orci, L. (1999). Regulation of fatty acid homeostasis in cells: 
Novel role of leptin. Proceedings of the National Academy of Sciences of the United States 
of America, 96(5), 2327-2332.  
Unger, R. H., & Orci, L. (2010). Paracrinology of islets and the paracrinopathy of diabetes. 
Proceedings of the National Academy of Sciences of the United States of America, 107(37), 
16009-16012. doi:10.1073/pnas.1006639107  
Vasavada, R. C., Garcia-Ocana, A., Zawalich, W. S., Sorenson, R. L., Dann, P., Syed, M., . . . 
Stewart, A. F. (2000). Targeted expression of placental lactogen in the beta cells of 
transgenic mice results in beta cell proliferation, islet mass augmentation, and 
hypoglycemia. Journal of Biological Chemistry, 275(20), 15399-15406. 
doi:http://dx.doi.org/10.1074/jbc.275.20.15399  
Vasavada, R. C., Wang, L., Fujinaka, Y., Takane, K. K., Rosa, T. C., Mellado-Gil, J., . . . Garcia-
Ocaña, A. (2007). Protein kinase C-zeta activation markedly enhances beta-cell 
proliferation: An essential role in growth factor mediated beta-cell mitogenesis. Diabetes, 
56(11), 2732-2743.  
Vaulont, S., Vasseur-Cognet, M., & Kahn, A. (2000). Glucose regulation of gene transcription. 
The Journal of Biological Chemistry, 275(41), 31555-31558.  
Wang, J., Qian, X., Chinookoswong, N., Lu, J., Chow, G., Theill, L. E., & Shi, Z. (2002). 
Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces 
incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic 
mice. Endocrinology, 143(9), 3490-3497.  
Wang, R. N., Paraskevas, S., & Rosenberg, L. (1999). Characterization of integrin expression in 
islets isolated from hamster, canine, porcine, and human pancreas. The Journal of 
Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 47(4), 
499-506.  
Wang, R. N., & Rosenberg, L. (1999). Maintenance of beta-cell function and survival following 
islet isolation requires re-establishment of the islet-matrix relationship. The Journal of 
Endocrinology, 163(2), 181-190.  
Weber, L. M., Cheung, C. Y., & Anseth, K. S. (2008). Multifunctional pancreatic islet 




Weber, L. M., Hayda, K. N., & Anseth, K. S. (2008). Cell-matrix interactions improve beta-cell 
survival and insulin secretion in three-dimensional culture. Tissue Engineering.Part A, 
14(12), 1959-1968.  
Weber, L. M., Hayda, K. N., Haskins, K., & Anseth, K. S. (2007). The effects of cell-matrix 
interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-
derived adhesive peptides. Biomaterials, 28(19), 3004-3011.  
Withers, D. J., Julio Sanchez Gutierrez, Towery, H., Burks, D. J., & et al. (1998). Disruption of 
IRS-2 causes type 2 diabetes in mice. Nature, 391(6670), 900-4. 
doi:http://dx.doi.org/10.1038/36116  
Wojtusciszyn, A., Armanet, M., Morel, P., Berney, T., & Bosco, D. (2008). Insulin secretion 
from human beta cells is heterogeneous and dependent on cell-to-cell contacts. 
Diabetologia, 51(10), 1843-1852. doi:10.1007/s00125-008-1103-z  
Wu, H., Avgoustiniatos, E. S., Swette, L., Bonner-Weir, S., Weir, G. C., & Colton, C. K. (1999). 
In situ electrochemical oxygen generation with an immunoisolation device. Annals of the 
New York Academy of Sciences, 875, 105-125.  
You, M., Kwak, M. K., Kim, D., Kim, K., Levchenko, A., Kim, D., & Suh, K. (2010). 
Synergistically enhanced osteogenic differentiation of human mesenchymal stem cells by 
culture on nanostructured surfaces with induction media. Biomacromolecules, 11(7), 1856-
1862. doi:10.1021/bm100374n  
